Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Objects To Claims Based On Low-Quality Evidence In DTC Ads

Apr 26 2010

• By The Pink Sheet

Related Content

DDMAC Says GSK Ad Is Branded Even Without Mention Of Drug Name

Apr 20 2010

Watching Your Language: FDA Ad Division Objects To User-Friendly Efficacy Claims With Jargon-y Risk Info

Feb 08 2010

Testimonials Lead To Overbroad Claims, DDMAC Warning Letter Says

Apr 19 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window